[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339093-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339093-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","barriers-and-unequal-access-to-timely-molecular-testing-results-addressing-the-inequities-in-cancer-care-delays-across-canada","Barriers and Unequal Access to Timely Molecular Testing Results: Addressing the Inequities in Cancer Care Delays across Canada","","Genomic medicine improves cancer diagnosis and outcomes by enabling the right treatment at the right dose for the right patient, yet timely biomarker testing and reporting remain uneven. A 2023 Canadian conference convened leaders across tumor types to identify education-, delivery-, laboratory-, patient-, and health-system level challenges and opportunities. Reported barriers included low awareness, insufficient clinician–patient discussion, delays or lack of hereditary testing, slow result reporting, inter- and intraprovincial disparities, limited funding, nonstandardized testing, and social determinants of health. Standardization and priority access to advanced molecular testing are needed to reduce inequities across Canada.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/barriers-and-unequal-access-to-timely-molecular-testing-results-addressing-the-inequities-in-cancer-care-delays-across-canada/339093/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/barriers-and-unequal-access-to-timely-molecular-testing-results-addressing-the-inequities-in-cancer-care-delays-across-canada/339093.png","ImageObject",300,407,{"name":42,"@type":43},"Lucas Martin","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of the 2023 Canadian conference discussed in the document?","Question",{"text":63,"@type":64},"To identify challenges and opportunities to improve equitable and timely access to biomarker testing and reporting across education, delivery, laboratory, patient, and health-system levels in Canada.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which major barriers to timely biomarker testing and results reporting were identified?",{"text":68,"@type":64},"Barriers included limited awareness of genomic medicine options, clinicians not discussing genomic medicine with patients, delays or lack of hereditary testing, lack of timely result reporting, provincial disparities, insufficient funding, lack of standardized testing, and effects of social determinants of health.",{"name":70,"@type":61,"acceptedAnswer":71},"What recommendations are emphasized to address inequities in cancer care delays?",{"text":72,"@type":64},"Canada should standardize biomarker testing approaches nationwide and prioritize access to advanced molecular testing so systems can rapidly deliver innovation and evidence-based treatments regardless of residence or socioeconomic status.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339093,1790301244,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Conference Report  \nBarriers and Unequal Access to Timely Molecular Testing Results: Addressing the Inequities in Cancer Care Delays across Canada  \nStephanie Snow 1, Christine Brezden-Masley 2, Michael D. Carter 3, Neesha Dhani 4, Cassandra Macaulay 5, Ravi Ramjeesingh 1, Michael J. Raphael 6, Monika Slovinec D’Angelo 5 and Filomena Servidio-Italiano 5, *  \nCitation: Snow, S.; Brezden-Masley, C.; Carter, M.D.; Dhani, N.; Macaulay, C.; Ramjeesingh, R.; Raphael, M.J.; Slovinec D’Angelo, M.;  \nServidio-Italiano, F. Barriers and Unequal Access to Timely Molecular Testing Results: Addressing the Inequities in Cancer Care Delays across Canada. Curr. Oncol. 2024, 31, 1359–1375. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)curroncol31030103  \nReceived: 30 January 2024  \nRevised: 26 February 2024  \nAccepted: 28 February 2024  \nPublished: 6 March 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Division of Medical Oncology, QEII Health Sciences Centre, Halifax, NS B3H 2Y9, Canada  \n2 Division of Medical Oncology, Sinai Health, Toronto, ON M5G 1X5, Canada  \n3 Division of Anatomical Pathology, QEII Health Sciences Centre, Halifax, NS B3H 2Y9, Canada  \n4 Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada  \n5 Colorectal Cancer Resource & Action Network (CCRAN), Toronto, ON M4W 3E2, Canada  \n6 Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada  \n* [Correspondence: filomena.s@ccran.org](Correspondence: filomena.s@ccran.org); Tel.: +1-905-417-0726 (ext. 1000); Fax: +1-905-303-2698  \nAbstract: Genomic medicine is a powerful tool to improve diagnosis and outcomes for cancer patients by facilitating the delivery of the right drug at the right dose at the right time for the right patient. In 2023, a Canadian conference brought together leaders with expertise in different tumor types. The objective was to identify challenges and opportunities for change in terms of equitable and timely access to biomarker testing and reporting at the education, delivery, laboratory, patient, and healthsystem levels in Canada. Challenges identified included: limited patient and clinician awareness of genomic medicine options with need for formal education strategies; failure by clinicians to discuss genomic medicine with patients; delays in or no access to hereditary testing; lack of timely reporting of results; intra-and inter-provincial disparities in access; lack of funding for patients to access testing and for laboratories to provide testing; lack of standardized testing; and impact of social determinants of health. Canada must standardize its approach to biomarker testing across the country, with a view to addressing current inequities, and prioritize access to advanced molecular testing to ensure systems are in place to quickly bring innovation and evidence-based treatments to Canadian cancer patients, regardless of their place of residence or socioeconomic status.  \nKeywords: biomarker; biomarker testing; biomarker status; circulating tumor DNA (ctDNA); comprehensive genomic profiling; health systems; liquid biopsy; molecular testing; next generation sequencing; precision medicine  \n1. Introduction  \nCancer is the leading cause of death in Canada [1,2] and 45% of Canadians can expect to be diagnosed with cancer during their lifetime [3] . In 2021, cancer-related costs in Canada were estimated at USD 26.2 billion, 30% of which were borne by patients and their families [4] .  \nAccording to the Pan-Cancer Analysis of Whole Genomes Consortium, up to 95% of tumors have identifiable mutations that are responsible for tumor proli","cbCait912fink7ae","https://ap.wps.com/l/cbCait912fink7ae","pdf",262426,17,"English","# Introduction\n# Biomarker Conference\n## Impetus and Organization","[{\"question\":\"What was the purpose of the 2023 Canadian conference discussed in the document?\",\"answer\":\"To identify challenges and opportunities to improve equitable and timely access to biomarker testing and reporting across education, delivery, laboratory, patient, and health-system levels in Canada.\"},{\"question\":\"Which major barriers to timely biomarker testing and results reporting were identified?\",\"answer\":\"Barriers included limited awareness of genomic medicine options, clinicians not discussing genomic medicine with patients, delays or lack of hereditary testing, lack of timely result reporting, provincial disparities, insufficient funding, lack of standardized testing, and effects of social determinants of health.\"},{\"question\":\"What recommendations are emphasized to address inequities in cancer care delays?\",\"answer\":\"Canada should standardize biomarker testing approaches nationwide and prioritize access to advanced molecular testing so systems can rapidly deliver innovation and evidence-based treatments regardless of residence or socioeconomic status.\"}]","Barriers and Unequal Access to Timely Molecular Testing Results: Addressing the Inequities in Cancer Care Delays across Canada | PDF",1790027824,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/824c83237c041c18ba0db1d58bdd71b0.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c29660a3bfbc1bc8924500f927b217e2.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/63eda2ecbb450775dc1a473ddd046b1e.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21fa66fb3a71372dfc6130202795e087.webp",980,1385]